S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
New CBOE “special perk” helps traders target income every weekend (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
New CBOE “special perk” helps traders target income every weekend (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
New CBOE “special perk” helps traders target income every weekend (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
New CBOE “special perk” helps traders target income every weekend (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
New CBOE “special perk” helps traders target income every weekend (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months

RadNet (RDNT) Stock Price, News & Analysis

$36.22
+0.20 (+0.56%)
(As of 12/8/2023 08:57 PM ET)
Compare
Today's Range
$35.97
$36.69
50-Day Range
$25.42
$36.48
52-Week Range
$17.82
$36.73
Volume
419,700 shs
Average Volume
432,114 shs
Market Capitalization
$2.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.00

RadNet MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6.1% Downside
$34.00 Price Target
Short Interest
Bearish
3.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
0.74mentions of RadNet in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$451,427 Sold Last Quarter
Proj. Earnings Growth
-14.29%
From $0.42 to $0.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Medical Sector

805th out of 942 stocks

Medical Laboratories Industry

17th out of 18 stocks


RDNT stock logo

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

RDNT Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
What Wall Street expects from RadNet's earnings
RadNet Inc RDNT
Should Value Investors Buy RadNet (RDNT) Stock?
Jim Cramer Says This Major Telecom Stock Is 'Horrendous'
RadNet (RDNT) Q2 Earnings and Revenues Top Estimates
A Preview Of RadNet's Earnings
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/11/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$34.00
High Stock Price Target
$42.00
Low Stock Price Target
$30.00
Potential Upside/Downside
-6.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
2.49%

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$3.56 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
65,939,000
Market Cap
$2.50 billion
Optionable
Optionable
Beta
1.79

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 77)
    Chairman, President & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 52)
    Executive VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 37)
    Executive VP of Financial Planning & Analysis and Chief Administrative Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 67)
    President & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 62)
    President & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 60)
    Senior VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 67)
    Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 61)
    Executive VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 58)
    Executive VP, Chief Legal Officer & Corporate Secretary














RDNT Stock Analysis - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price target for 2024?

3 Wall Street analysts have issued twelve-month target prices for RadNet's stock. Their RDNT share price targets range from $30.00 to $42.00. On average, they predict the company's stock price to reach $34.00 in the next year. This suggests that the stock has a possible downside of 6.1%.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2023?

RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT stock has increased by 92.4% and is now trading at $36.22.
View the best growth stocks for 2023 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) issued its quarterly earnings results on Wednesday, November, 8th. The medical research company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.08. The medical research company had revenue of $401.97 million for the quarter, compared to the consensus estimate of $391.63 million. RadNet had a net margin of 0.25% and a trailing twelve-month return on equity of 4.16%. The business's revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.09 EPS.

What guidance has RadNet issued on next quarter's earnings?

RadNet updated its FY 2023 earnings guidance on Wednesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.60 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

Who are RadNet's major shareholders?

RadNet's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Invesco Ltd. (2.17%), Principal Financial Group Inc. (1.71%), Punch & Associates Investment Management Inc. (1.54%), American Century Companies Inc. (1.10%), Loomis Sayles & Co. L P (0.97%) and Northern Trust Corp (0.95%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:RDNT) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -